Concepedia

Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat

Shalea Piteau, Amy Olver, Su‐jin Kim, Kyle D. Winter, J. Andrew Pospisilik, Francis C. Lynn, Susanne Manhart, Hans‐Ulrich Demuth, Madeleine Speck, Raymond A. Pederson,

Biochemical and Biophysical Research Communications · 2007 · 129 citations · 27 references

DOI

Concepts

References

27

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Michael A. Nauck, Markus M. Heimesaat, Jens J. Holst et al. · Journal of Clinical Investigation · 1993 · 1.6K citations · Full text

, , +15

Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

Michael A. Nauck, F. Stöckmann, R. Ebert et al. · Diabetologia · 1986 · 1.3K citations · Full text

, , +13

Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients

Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon et al. · Diabetes · 2001 · 884 citations · Full text

, , +16

Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas.

Doris A. Stoffers, Timothy J. Kieffer, Mehboob A. Hussain et al. · Diabetes · 2000 · 579 citations · Full text

, , +17

Downregulation of GLP-1 and GIP Receptor Expression by Hyperglycemia

Gang Xu, Hideaki Kaneto, D. Ross Laybutt et al. · Diabetes · 2007 · 368 citations · Full text

, , +17